Expertise in
5
conditions

Mark W. Webster

Green Lane Cardiovascular Service, 
Auckland, AUK, NZ 
Expertise in
5
conditions
Green Lane Cardiovascular Service, 
Auckland, AUK, NZ 

Overview

Mark Webster practices practicing medicine in Auckland, New Zealand.

Mr. Webster is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Acute Coronary Syndrome, Aortic Valve Stenosis, Percutaneous Coronary Intervention (PCI), and Angioplasty.

He is actively involved in clinical research, co-authoring 106 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Green Lane Cardiovascular Service, Auckland, AUK, New Zealand
Other Locations
Green Lane Cardiovascular Services/Cardiology Department, Te Toka Tumai Auckland, Park Road, Grafton, AUK 1142, New Zealand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Multi-center, Single-Arm Feasibility Study of the transShield Embolic Protection System
Prospective, Multi-center, Single-Arm Feasibility Study of the transShield Embolic Protection System
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Device
Study Phase: Not Applicable
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Enrollment Status: Completed
Publish Date: May 14, 2021
Intervention Type: Device
Study Phase: Phase 3
Evaluation of a Thin Strut Metallic Coronary Device: the Elixir DynamXTM Sirolimus Eluting Coronary Bioadaptor System
Evaluation of a Thin Strut Metallic Coronary Device: the Elixir DynamXTM Sirolimus Eluting Coronary Bioadaptor System
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Device
Study Phase: Not Applicable
Onyx ONE Study; A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients
Onyx ONE Study; A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients
Enrollment Status: Completed
Publish Date: December 02, 2020
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Multi-Center, Single Arm Study of the Medeon Biodesign XPro™ Suture-Mediated Vascular Closure Device System
Prospective, Multi-Center, Single Arm Study of the Medeon Biodesign XPro™ Suture-Mediated Vascular Closure Device System
Enrollment Status: Completed
Publish Date: September 20, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

106 Total Publications

EXPRESS: Multi-modal Magnetic Resonance Imaging to Assess Cerebrovascular Function in Patients with Atrial Fibrillation.
EXPRESS: Multi-modal Magnetic Resonance Imaging to Assess Cerebrovascular Function in Patients with Atrial Fibrillation.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: June 25, 2026

Frequently Asked Questions about Mark W. Webster

Is Mark W. Webster a top-rated expert for Coronary Heart Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Mark W. Webster is classified as an Advanced expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mark W. Webster participate in research or clinical trials?

Yes. Mark W. Webster has published 106 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Mark W. Webster's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Webster's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile